These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 32505512)

  • 1. Third human challenge trial conference, Oxford, United Kingdom, February 6-7, 2020, a meeting report.
    Pollard AJ; Sauerwein R; Baay M; Neels P;
    Biologicals; 2020 Jul; 66():41-52. PubMed ID: 32505512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Typhoidal Salmonella human challenge studies: ethical and practical challenges and considerations for low-resource settings.
    Raymond M; Gibani MM; Day NPJ; Cheah PY
    Trials; 2019 Dec; 20(Suppl 2):704. PubMed ID: 31852488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 controlled human infection models: Ethics, challenge agent production and regulatory issues.
    Baay M; Neels P
    Biologicals; 2020 Sep; 67():69-74. PubMed ID: 32829985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review of the current status of enteric vaccines.
    Levine MM; Noriega F
    P N G Med J; 1995 Dec; 38(4):325-31. PubMed ID: 9522876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing public perception of a sand fly biting study on the pathway to a controlled human infection model for cutaneous leishmaniasis.
    Parkash V; Jones G; Martin N; Steigmann M; Greensted E; Kaye P; Layton AM; Lacey CJ
    Res Involv Engagem; 2021 May; 7(1):33. PubMed ID: 34053461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Developing and utilizing controlled human models of infection.
    Porter CK; Louis Bourgeois A; Frenck RW; Prouty M; Maier N; Riddle MS
    Vaccine; 2017 Dec; 35(49 Pt A):6813-6818. PubMed ID: 28583306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [News in the field of epidemiology].
    Birtasević B; Vuksić L; Dordević D
    Vojnosanit Pregl; 1969 Nov; 26(11):559-62. PubMed ID: 4908249
    [No Abstract]   [Full Text] [Related]  

  • 8. Consensus Report on Shigella Controlled Human Infection Model: Introduction and Overview.
    MacLennan CA; Aguilar AO; Steele AD
    Clin Infect Dis; 2019 Dec; 69(Suppl 8):S577-S579. PubMed ID: 31816066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meeting report: Convening on the influenza human viral challenge model for universal influenza vaccines, Part 1: Value; challenge virus selection; regulatory, industry and ethical considerations; increasing standardization, access and capacity.
    Innis BL; Berlanda Scorza F; Blum JS; Jain VK; Older Aguilar A; Post DJ; Roberts PC; Wairagkar N; White J; Bresee J
    Vaccine; 2019 Aug; 37(35):4823-4829. PubMed ID: 31362819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ACQUIRED IMMUNITY: BACTERIAL INFECTIONS.
    CRUICKSHANK R
    Mod Trends Immunol; 1963; 1():107-29. PubMed ID: 14138636
    [No Abstract]   [Full Text] [Related]  

  • 11. Bioethics of establishing a CHIM model for dengue vaccine development.
    Rose A; Sekhar A
    Int J Infect Dis; 2019 Jul; 84S():S74-S79. PubMed ID: 30641207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human challenge trial workshop: Focus on quality requirements for challenge agents, Langen, Germany, October 22, 2019.
    Bekeredjian-Ding I; Van Molle W; Baay M; Neels P;
    Biologicals; 2020 Jul; 66():53-61. PubMed ID: 32389512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What risks should be permissible in controlled human infection model studies?
    Binik A
    Bioethics; 2020 May; 34(4):420-430. PubMed ID: 32115747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transport in the tropics of faecal samples for bacteriological examination for typhoid and paratyphoid fever and bacillary dysentery.
    KRANENDONK O; van NOORD
    Trop Geogr Med; 1960 Dec; 12():345-55. PubMed ID: 13753960
    [No Abstract]   [Full Text] [Related]  

  • 15. Oral vaccination against enteric bacterial infections: an overview.
    Germanier R
    Behring Inst Mitt; 1984 Nov; (76):98-105. PubMed ID: 6395852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homologous and heterologous re-challenge with Salmonella Typhi and Salmonella Paratyphi A in a randomised controlled human infection model.
    Gibani MM; Jin C; Shrestha S; Moore M; Norman L; Voysey M; Jones E; Blackwell L; Thomaides-Brears H; Hill J; Blohmke CJ; Dobinson HC; Baker P; Jones C; Campbell D; Mujadidi YF; Plested E; Preciado-Llanes L; Napolitani G; Simmons A; Gordon MA; Angus B; Darton TC; Cerundulo V; Pollard AJ
    PLoS Negl Trop Dis; 2020 Oct; 14(10):e0008783. PubMed ID: 33079959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Legally designated infectious diseases].
    Hiraishi HK
    Naika; 1972; 29(2):246-52. PubMed ID: 4623138
    [No Abstract]   [Full Text] [Related]  

  • 18. Using a Human Challenge Model of Infection to Measure Vaccine Efficacy: A Randomised, Controlled Trial Comparing the Typhoid Vaccines M01ZH09 with Placebo and Ty21a.
    Darton TC; Jones C; Blohmke CJ; Waddington CS; Zhou L; Peters A; Haworth K; Sie R; Green CA; Jeppesen CA; Moore M; Thompson BA; John T; Kingsley RA; Yu LM; Voysey M; Hindle Z; Lockhart S; Sztein MB; Dougan G; Angus B; Levine MM; Pollard AJ
    PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004926. PubMed ID: 27533046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral vaccination against enteric bacterial infections: an overview.
    Germanier R
    Infection; 1984; 12(2):138-42. PubMed ID: 6376365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Principles for the state control of oral vaccines against bacterial intestinal infections].
    Thilo W
    Z Gesamte Hyg; 1975; 21(12):888-91. PubMed ID: 820097
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.